US FDA approves first 'digital pill'
The U.S. Food and Drug Administration (FDA) on Monday approved a “digital pill” for the first time ever, but a consumer advocate group said Tuesday its users should be wary, APA reports quoting AA.
The pill is equipped with a tiny sensor that transmits data about whether the patient had taken the pill or not.
Though the move has been lauded as a milestone for the infant field of digital medicine, some are raising concerns about privacy and costs.
Named Abilify MyCite, the medication is produced by Otsuka Pharmaceutical based in Japan and is outfitted with a sensor built by a company called Proteus Digital Health. Abilify, the drug, is an antipsychotic medicine used to treat mental illnesses like bipolar disorder and schizophrenia.
The sensor, about the size of a grain of sand, is activated when it comes into contact with stomach acid. It transmits data to a patch that, in turn, can send information to a smartphone app that lets family members or caretakers know that a patient took the medication.
“Being able to track ingestion of medications prescribed for mental illness may be useful for some patients,” Mitchell Mathis, director of the Division of Psychiatry Products in the FDA’s Center for Drug Evaluation and Research, said in a statement Monday.
“The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers.”
The creators of Abilify MyCite believe it will lead the way toward other medications solving the issue of nonadherence, i.e., when patients do not follow the treatment instructions of their doctors.
“The time is right for the category of digital medicines to be available to appropriate patients with serious mental illness,” Proteus CEO Andrew Thompson said in a statement released Tuesday.
“Consumers already manage important tasks like banking, shopping and communicating with friends and family by using their smartphones as they go about their daily lives.”
The ability to track someone’s medicine intake, however, is unnerving some digital privacy advocates like the Electronic Frontier Foundation.
“Before you swallow one of these — just like with any other device — make sure you know what sensitive medical data is being collected about you and how it's being used and stored,” the group said Tuesday on Twitter
Related news releases
- 18.11.20179 injured in large fire atop 6-story apartment building in New York
- 18.11.2017Argentine submarine goes missing for two days, major search op underway
- 18.11.2017Canada, Mexico try more flexibility as key NAFTA round opens
- 17.11.2017US official: If Turkey buys Russian systems, they can’t plug into NATO tech
- 17.11.2017Turkish businessman Reza Zarrab escapes knife attack in U.S. prison
- 17.11.2017Canadian senator dies on parliamentary trip in Colombia
- 17.11.2017South Dakota Keystone pipeline shut down after oil spill
- 17.11.2017UN Security Council rejects Russian draft on Syria chemical probe
- 17.11.2017The impeachment of President Donald Trump has officially begun
- 17.11.2017Fed's Williams calls for global rethink of monetary policy
- 17.11.2017US House passes tax reform bill, sends measure to Senate
- 16.11.2017Trump urges U.N. council to renew Syria chemical arms inquiry
- 16.11.2017More worries in Congress over cuts at U.S. State Department
- 14.11.2017Trump vows free and open Indo-Pacific region
- 14.11.2017US Army lifts ban on recruits with mental health history
- 12.11.2017Six people killed in bus-hearse crash in Mexico
- 12.11.2017Geneva talks should be the only platform for Syrian settlement - State Department
- 12.11.2017Mass graves discovered near Hawija in Iraq
- 12.11.2017Venezuela sets high-profile location for Monday debt talks
- 11.11.2017APEC ministers publish joint statement after wrangling over language
- 11.11.2017Oil prices slide after U.S. drillers add rigs
- 10.11.2017Colombia 'committed' to deal with FARC
- 10.11.2017Turkish premier urges US to extradite FETO leader
- 10.11.2017State Dept. denies report top envoys being depleted
- 09.11.2017US imposes sanctions on Venezuela: Senior gov't officials on the list
- 09.11.2017Turkish premier, US vice president meet at White House
- 09.11.2017US lawmakers renew gun control bid after Texas shooting
- 09.11.2017U.N. warns if no Yemen aid access, world will see largest famine in decades
- 09.11.2017Trump to talk trade and North Korea with Chinese leader Xi
- 09.11.2017US tightens restrictions on travel to Cuba
- 08.11.2017US blames Iran for missile attack on Saudi airport
- 08.11.2017Twitter rolls out 280-character tweets to most users
- 08.11.2017Texas shooting: Gunman 'escaped mental hospital in 2012'
- 08.11.2017US Navy’s next-gen ballistic missile submarines just got cheaper
- 07.11.2017House Republicans seek U.S. tax vote next week; Fitch warns on deficit
- 07.11.2017Senate banking panel backs new North Korea sanctions
- 07.11.2017Trump requests over $5bln extra defense spending for North Korea, Afghanistan
- 05.11.2017US senator Rand Paul assaulted at home in Kentucky
- 04.11.2017U.S. warns of threat to diplomatic staff in Somali capital
- 04.11.2017Twitter responds after Trump’s account deactivated
- 15.11.2017U.S. security officials arrive in Israel to discuss Syria agreement
- 15.11.2017Planned talks between Venezuelan opposition, government will not take place
- 16.11.2017US Democrats enter new articles to impeach Trump
- 15.11.2017Death toll as a result of a gunman in California fired at school reached - UPDATED
- 15.11.2017De Mistura: Putin, Trump create qualitatively new situation in Syrian settlement
- 14.11.2017At least 3 dead in California school shooting, shooter killed by police